1-4 of 4
Paul A.S. Evans
Close
Sort by
Journal Articles

Differential Protein Expression in MBL and CLL: LAIR1 Is a Powerful Surface Marker for Identifying Cases with Adverse Cellular Features.

Andy C Rawstron, BSc, PhD, Darren J Newton, Ruth M. de Tute, Jane Shingles, Fiona L Bennett, Paul A.S. Evans, Sheila J.M. O’Connor, Andrew S Jack, Peter Hillmen
Journal: Blood
Blood (2008) 112 (11): 2076.
https://doi.org/10.1182/blood.V112.11.2076.2076
Published: 2008
Journal Articles

Tropical Splenic Lymphoma: Splenic Marginal Zone Lymphoma or Distinct Entity?.

Elizabeth A. Stephens, MBBS, Imelda Bates, MD, George Bedu-Addo, Ivy Ekem, Yvonne Dei, Ohene K. Opare-Sem, Sheila J.M. O’Connor, PhD, Paul A.S. Evans, PhD, Rebecca A. Rollett, BSc, Roger G. Owen, MD
Journal: Blood
Blood (2006) 108 (11): 4654.
https://doi.org/10.1182/blood.V108.11.4654.4654
Published: 2006
Journal Articles

Increased Expression of CD200 Antigen, a Potential Immunotherapeutic Target, Is Consistently Found in CLL Cells Irrespective of Biological Features.

Fiona L. Bennett, BSc, Andy C. Rawstron, PhD, Sheila J.M. O’Connor, PhD, Paul A.S. Evans, PhD, Peter Hillmen, MD, PhD
Journal: Blood
Blood (2006) 108 (11): 2815.
https://doi.org/10.1182/blood.V108.11.2815.2815
Published: 2006
Journal Articles

Differential Clearance Kinetics and Phenotypic Alterations of Leukaemic Blast Cells during Induction Therapy for Hyperdiploid and t(12;21) Childhood ALL: Implications for Minimal Residual Disease Detection by Flow Cytometry and Clinical Outcome.

Matthew J. Cullen, MSc, Anita J. Dickinson, MSc, Helen Dickinson, BSc, Michael A. Short, BSc, Paul A.S. Evans, PhD, Sally E. Kinsey, MD, Mike Richards, MD, Stephen J. Richards, PhD
Journal: Blood
Blood (2004) 104 (11): 991.
https://doi.org/10.1182/blood.V104.11.991.991
Published: 2004